This study provides insights into mechanisms that accelerate the progression of obesity‐associated inflammation toward insulin resistance and T2DM and further demonstrates the potential of targeting transcriptional coregulator of ATM for treating insulin resistance. Here, ATM is linked to type 2 diabetes mellitus.